Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/26349
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhanna, H K-
dc.contributor.authorNagin, Chand-
dc.date.accessioned2014-02-04T05:33:47Z-
dc.date.available2014-02-04T05:33:47Z-
dc.date.issued2002-03-
dc.identifier.issn0975-1084 (Online); 0022-4456 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/26349-
dc.description167-183en_US
dc.description.abstractThe paper covers the following aspects: An introduction of the structure of the industry, details about the importance of research and patents in this sector worldwide, difference between basic and process R&D, the anomalies in India and changes imminent under WTO. The global scenario including industry size, growth, regional market shares, therapeutic segmentation, major players and brands. It also provides details about how managed health care works, its repercussions on drug prices and opportunities in the US generics market, The Indian scenario gives the historical backdrop, present status, growth projections, changing strategies in the face of WTO, export opportunities and future prospects. A detailed coverage of DPCO (Drug Price Control Order), its evolution since 1 970, present status, recent drug policy, coverage under DPCO ' 95, drugs under price control. their notified prices and major formulations.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceJSIR Vol.61(03) [March 2002]en_US
dc.titleGlobal Scenario of Pharmaceutical Industry with Special Reference to Indian Pharmaceutical Industryen_US
dc.typeArticleen_US
Appears in Collections:JSIR Vol.61(03) [March 2002]

Files in This Item:
File Description SizeFormat 
JSIR 61(3) 167-183.pdf2.54 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.